Dr. Tara Narula Cangello, MD

Dr. Cangello practices at Northwell Health Physician Partners Cardiology in New York, New York.

Dr. Cangello's NPI, 1427127547, was assigned on November 6, 2006. Dr. Cangello holds New York license 243732.

Dr. Cangello's primary practice is Northwell Health Physician Partners Cardiology, at 110 E 59th St, New York, NY 10022 in New York County. The practice phone is (516) 321-7400.

Dr. Cangello's primary practice is Northwell Health Physician Partners Cardiology in New York, New York. Dr. Cangello is also affiliated with Lenox Hill Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Cangello to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cangello practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cangello's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Cangello's licenses on file in 2 states: New York and Massachusetts.

CMS data shows 1,350 Medicare services from Dr. Cangello across 7 procedure codes in 2024, for 256 Medicare patients. Medicare paid $67,450 for them. Every service was in an office.

CMS counts 256 Medicare patients who saw Dr. Cangello in 2024. The largest group is 75 to 84, with 110 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cangello's median patient age at 62, with 65% women.

In 2024, Dr. Cangello wrote 2,686 Medicare Part D claims for 360 patients. 88% of them were for generic drugs. CMS names the drug for 2,518 of them, across 27 drugs with 11 or more claims each, at $254,835 in total drug cost. In 2023, CMS named 2,022 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Cangello for performance year 2024, reported through an alternative payment model (APM). Dr. Cangello accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cangello as offering telehealth.

CMS Open Payments shows 8 general payments to Dr. Cangello from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $208.